Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Tumor Necrosis Factor, Type II | 16 | 2024 | 357 | 6.250 |
Why?
|
Diabetes Mellitus, Type 1 | 56 | 2023 | 3338 | 5.570 |
Why?
|
BCG Vaccine | 12 | 2023 | 369 | 4.000 |
Why?
|
T-Lymphocytes, Regulatory | 16 | 2022 | 2988 | 2.120 |
Why?
|
Spleen | 20 | 2020 | 2359 | 1.920 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2023 | 595 | 1.870 |
Why?
|
Autoimmune Diseases | 17 | 2021 | 2134 | 1.670 |
Why?
|
Tumor Necrosis Factor-alpha | 17 | 2024 | 4422 | 1.530 |
Why?
|
Sezary Syndrome | 3 | 2020 | 76 | 1.510 |
Why?
|
Sjogren's Syndrome | 9 | 2014 | 234 | 1.320 |
Why?
|
Cysteine Endopeptidases | 11 | 2009 | 563 | 1.320 |
Why?
|
Islets of Langerhans | 22 | 2020 | 1350 | 1.290 |
Why?
|
Mice, Inbred NOD | 28 | 2014 | 1876 | 1.270 |
Why?
|
C-Peptide | 5 | 2015 | 420 | 1.020 |
Why?
|
ATP-Binding Cassette Transporters | 10 | 2003 | 560 | 0.970 |
Why?
|
Islets of Langerhans Transplantation | 16 | 2006 | 745 | 0.930 |
Why?
|
Autoimmunity | 12 | 2018 | 1349 | 0.930 |
Why?
|
Cell Transplantation | 5 | 2007 | 478 | 0.920 |
Why?
|
Multienzyme Complexes | 8 | 2003 | 686 | 0.900 |
Why?
|
Freund's Adjuvant | 5 | 2007 | 139 | 0.890 |
Why?
|
Gene Regulatory Networks | 2 | 2022 | 1707 | 0.870 |
Why?
|
Histocompatibility Antigens Class I | 16 | 2002 | 1366 | 0.870 |
Why?
|
Lymphocytes | 14 | 2015 | 2615 | 0.860 |
Why?
|
Mycobacterium bovis | 1 | 2022 | 150 | 0.820 |
Why?
|
Insulin-Secreting Cells | 4 | 2013 | 889 | 0.710 |
Why?
|
NF-kappa B | 12 | 2017 | 2500 | 0.700 |
Why?
|
Stem Cell Transplantation | 6 | 2010 | 1620 | 0.690 |
Why?
|
Antibodies, Neoplasm | 1 | 2020 | 286 | 0.680 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2020 | 197 | 0.670 |
Why?
|
Homeodomain Proteins | 7 | 2010 | 2419 | 0.630 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 480 | 0.610 |
Why?
|
Genes, MHC Class II | 6 | 2003 | 457 | 0.600 |
Why?
|
Apoptosis | 11 | 2023 | 9718 | 0.580 |
Why?
|
Regeneration | 7 | 2020 | 1486 | 0.580 |
Why?
|
Genes, MHC Class I | 5 | 1998 | 258 | 0.580 |
Why?
|
Communicable Diseases | 2 | 2022 | 880 | 0.570 |
Why?
|
Stem Cell Niche | 2 | 2010 | 346 | 0.560 |
Why?
|
Signal Transduction | 12 | 2024 | 23398 | 0.560 |
Why?
|
Blood Glucose | 11 | 2023 | 6259 | 0.550 |
Why?
|
HLA Antigens | 3 | 2015 | 1382 | 0.550 |
Why?
|
Glycolysis | 1 | 2020 | 830 | 0.540 |
Why?
|
Tumor Microenvironment | 4 | 2022 | 3583 | 0.540 |
Why?
|
Immunotherapy | 5 | 2022 | 4437 | 0.540 |
Why?
|
Metformin | 1 | 2023 | 837 | 0.530 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 518 | 0.520 |
Why?
|
Major Histocompatibility Complex | 11 | 2003 | 936 | 0.520 |
Why?
|
Papain | 1 | 2015 | 64 | 0.520 |
Why?
|
Antibodies, Monoclonal | 9 | 2018 | 9272 | 0.510 |
Why?
|
T-Lymphocytes | 22 | 2012 | 10179 | 0.500 |
Why?
|
Mice | 60 | 2022 | 81154 | 0.480 |
Why?
|
Cell Separation | 5 | 2011 | 1750 | 0.470 |
Why?
|
Histocompatibility | 1 | 2015 | 330 | 0.470 |
Why?
|
Isoantigens | 2 | 2015 | 567 | 0.470 |
Why?
|
Immunosuppressive Agents | 3 | 2017 | 4152 | 0.450 |
Why?
|
Animals | 75 | 2022 | 168660 | 0.450 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2023 | 2248 | 0.450 |
Why?
|
Herpesvirus 4, Human | 5 | 2013 | 1041 | 0.450 |
Why?
|
Histocompatibility Antigens Class II | 10 | 2003 | 1475 | 0.440 |
Why?
|
beta 2-Microglobulin | 5 | 2001 | 315 | 0.430 |
Why?
|
Antigen Presentation | 5 | 2003 | 1283 | 0.410 |
Why?
|
Graft Survival | 11 | 2001 | 3734 | 0.400 |
Why?
|
Glutamate Decarboxylase | 2 | 2012 | 246 | 0.400 |
Why?
|
Colonic Neoplasms | 2 | 2021 | 2542 | 0.400 |
Why?
|
Autoantigens | 3 | 2008 | 892 | 0.400 |
Why?
|
Cell Proliferation | 5 | 2020 | 10477 | 0.390 |
Why?
|
Gene Expression | 7 | 2020 | 7793 | 0.390 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.390 |
Why?
|
Adjuvants, Immunologic | 3 | 2023 | 999 | 0.370 |
Why?
|
Proteasome Endopeptidase Complex | 10 | 2013 | 1335 | 0.340 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2003 | 1800 | 0.340 |
Why?
|
Insulin | 9 | 2015 | 6584 | 0.340 |
Why?
|
Polymorphism, Genetic | 5 | 2003 | 4326 | 0.340 |
Why?
|
Proto-Oncogene Proteins | 4 | 2010 | 4552 | 0.330 |
Why?
|
Biological Assay | 1 | 2012 | 650 | 0.330 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2010 | 1733 | 0.320 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2020 | 1821 | 0.320 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3706 | 0.310 |
Why?
|
Adult Stem Cells | 1 | 2010 | 216 | 0.310 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4561 | 0.310 |
Why?
|
Humans | 88 | 2024 | 743811 | 0.310 |
Why?
|
Proteins | 7 | 2002 | 6098 | 0.300 |
Why?
|
DNA Methylation | 1 | 2021 | 4286 | 0.300 |
Why?
|
Stem Cells | 6 | 2007 | 3566 | 0.290 |
Why?
|
CpG Islands | 2 | 2021 | 1170 | 0.290 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 570 | 0.280 |
Why?
|
Lymphocyte Subsets | 2 | 2005 | 315 | 0.270 |
Why?
|
Splenectomy | 1 | 2007 | 394 | 0.270 |
Why?
|
Vaccination | 4 | 2022 | 3275 | 0.260 |
Why?
|
Cluster Analysis | 2 | 2023 | 2712 | 0.260 |
Why?
|
Immunologic Factors | 1 | 2014 | 1580 | 0.250 |
Why?
|
Organ Transplantation | 1 | 2015 | 1140 | 0.250 |
Why?
|
Diseases in Twins | 3 | 2003 | 450 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8430 | 0.240 |
Why?
|
Research Support as Topic | 2 | 2006 | 705 | 0.230 |
Why?
|
Prediabetic State | 6 | 2001 | 499 | 0.230 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2007 | 651 | 0.230 |
Why?
|
Cell Death | 2 | 2020 | 1705 | 0.230 |
Why?
|
Protein Processing, Post-Translational | 5 | 2003 | 1986 | 0.220 |
Why?
|
Disease Models, Animal | 9 | 2018 | 18027 | 0.220 |
Why?
|
Neoplasms | 3 | 2022 | 21675 | 0.220 |
Why?
|
Lymphocyte Activation | 5 | 2018 | 5524 | 0.220 |
Why?
|
Autoantibodies | 7 | 2012 | 2037 | 0.220 |
Why?
|
Mice, Inbred BALB C | 11 | 2021 | 6380 | 0.210 |
Why?
|
H-2 Antigens | 3 | 2001 | 366 | 0.210 |
Why?
|
Cell Line, Tumor | 4 | 2020 | 16674 | 0.210 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1295 | 0.210 |
Why?
|
HMGN1 Protein | 1 | 2021 | 27 | 0.210 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4931 | 0.200 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2001 | 59 | 0.200 |
Why?
|
Ligands | 2 | 2020 | 3281 | 0.200 |
Why?
|
Regenerative Medicine | 1 | 2005 | 308 | 0.200 |
Why?
|
Antibodies | 2 | 2021 | 2459 | 0.200 |
Why?
|
Peptides | 6 | 2005 | 4406 | 0.200 |
Why?
|
Brucella abortus | 1 | 2020 | 12 | 0.190 |
Why?
|
Brucellosis | 1 | 2020 | 20 | 0.190 |
Why?
|
Antibody Specificity | 2 | 2020 | 1095 | 0.180 |
Why?
|
Cell Lineage | 5 | 2010 | 2506 | 0.180 |
Why?
|
Fetus | 1 | 2008 | 1880 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2009 | 4477 | 0.170 |
Why?
|
Gene Expression Regulation | 6 | 2021 | 12066 | 0.170 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2000 | 115 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11729 | 0.170 |
Why?
|
B-Lymphocytes | 7 | 2013 | 4665 | 0.170 |
Why?
|
Women, Working | 1 | 1999 | 87 | 0.160 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2018 | 91 | 0.160 |
Why?
|
Case-Control Studies | 6 | 2021 | 21733 | 0.160 |
Why?
|
Cells, Cultured | 8 | 2018 | 19232 | 0.160 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1520 | 0.160 |
Why?
|
Protein Stability | 1 | 2020 | 556 | 0.160 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2020 | 139 | 0.160 |
Why?
|
Protein Isoforms | 2 | 2020 | 1729 | 0.160 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3645 | 0.160 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 1998 | 55 | 0.150 |
Why?
|
HLA-DR Antigens | 2 | 1997 | 645 | 0.150 |
Why?
|
Transplantation, Isogeneic | 2 | 1994 | 257 | 0.150 |
Why?
|
Flow Cytometry | 7 | 2021 | 5973 | 0.150 |
Why?
|
Science | 1 | 1999 | 239 | 0.140 |
Why?
|
Cell Membrane | 2 | 2023 | 3749 | 0.140 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1723 | 0.140 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3622 | 0.140 |
Why?
|
Diabetes Mellitus | 3 | 2005 | 5752 | 0.140 |
Why?
|
Immunoassay | 1 | 2020 | 751 | 0.140 |
Why?
|
Transplantation, Heterotopic | 2 | 1994 | 175 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 1081 | 0.140 |
Why?
|
Exons | 2 | 2003 | 2438 | 0.140 |
Why?
|
Adult | 17 | 2023 | 213889 | 0.140 |
Why?
|
Leukocytes | 2 | 2000 | 2044 | 0.130 |
Why?
|
Lymphocyte Transfusion | 2 | 1995 | 236 | 0.130 |
Why?
|
Mice, Inbred C57BL | 14 | 2021 | 21824 | 0.130 |
Why?
|
Combined Modality Therapy | 3 | 2020 | 8637 | 0.130 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 275 | 0.130 |
Why?
|
Fertility | 1 | 2020 | 779 | 0.130 |
Why?
|
Insulin Antibodies | 2 | 1993 | 31 | 0.130 |
Why?
|
Raffinose | 1 | 2015 | 52 | 0.130 |
Why?
|
Protein Conformation | 4 | 2018 | 4009 | 0.130 |
Why?
|
Imidazoles | 1 | 2021 | 1206 | 0.130 |
Why?
|
Membrane Glycoproteins | 2 | 2003 | 3769 | 0.130 |
Why?
|
Transplantation, Heterologous | 6 | 2004 | 2378 | 0.130 |
Why?
|
Lupus Vulgaris | 2 | 2005 | 9 | 0.130 |
Why?
|
Central Nervous System | 2 | 2018 | 1358 | 0.130 |
Why?
|
Caseins | 1 | 2015 | 104 | 0.130 |
Why?
|
Female | 34 | 2023 | 380020 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 3389 | 0.120 |
Why?
|
Deoxyglucose | 1 | 2015 | 337 | 0.120 |
Why?
|
Organ Preservation Solutions | 1 | 2015 | 98 | 0.120 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11036 | 0.120 |
Why?
|
RNA, Messenger | 6 | 2013 | 13028 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1917 | 0.120 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3128 | 0.120 |
Why?
|
Salivary Gland Diseases | 1 | 2014 | 37 | 0.120 |
Why?
|
Antigens | 1 | 2000 | 1466 | 0.120 |
Why?
|
Graft Rejection | 5 | 1995 | 4398 | 0.120 |
Why?
|
Allopurinol | 1 | 2015 | 190 | 0.120 |
Why?
|
Immunophenotyping | 1 | 2018 | 1880 | 0.120 |
Why?
|
Diabetes Mellitus, Experimental | 7 | 2006 | 1115 | 0.120 |
Why?
|
Submandibular Gland | 1 | 2013 | 86 | 0.120 |
Why?
|
Amino Acid Sequence | 3 | 2020 | 13809 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10940 | 0.110 |
Why?
|
Alternative Splicing | 1 | 1999 | 1117 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 3 | 2009 | 1837 | 0.110 |
Why?
|
Sialadenitis | 1 | 1993 | 43 | 0.110 |
Why?
|
Antigenic Modulation | 1 | 1992 | 11 | 0.110 |
Why?
|
Antigens, CD | 3 | 1993 | 4026 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2009 | 0.110 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 834 | 0.110 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2003 | 91 | 0.110 |
Why?
|
Immunoglobulin Fragments | 1 | 1992 | 84 | 0.110 |
Why?
|
Hypoglycemia | 1 | 2020 | 861 | 0.110 |
Why?
|
Hypersensitivity | 1 | 2021 | 1102 | 0.110 |
Why?
|
Drug Dosage Calculations | 1 | 2013 | 114 | 0.110 |
Why?
|
Glutathione | 1 | 2015 | 590 | 0.110 |
Why?
|
Uterine Neoplasms | 1 | 2002 | 1513 | 0.110 |
Why?
|
Multiple Sclerosis | 2 | 2018 | 3079 | 0.100 |
Why?
|
Immune Tolerance | 4 | 2018 | 2258 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3547 | 0.100 |
Why?
|
Fas Ligand Protein | 2 | 2003 | 216 | 0.100 |
Why?
|
Protein Binding | 3 | 2018 | 9377 | 0.100 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1613 | 0.100 |
Why?
|
Gene Deletion | 2 | 1999 | 2749 | 0.100 |
Why?
|
Cold Temperature | 1 | 2015 | 771 | 0.100 |
Why?
|
Cell Differentiation | 5 | 2010 | 11478 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2001 | 2583 | 0.100 |
Why?
|
Virus Activation | 1 | 2013 | 319 | 0.100 |
Why?
|
Substrate Specificity | 1 | 2015 | 1802 | 0.100 |
Why?
|
Leadership | 1 | 1999 | 1357 | 0.090 |
Why?
|
Ovary | 1 | 1994 | 980 | 0.090 |
Why?
|
Adenosine | 1 | 2015 | 825 | 0.090 |
Why?
|
Gene Transfer Techniques | 1 | 1995 | 1224 | 0.090 |
Why?
|
Rosette Formation | 1 | 1989 | 153 | 0.090 |
Why?
|
Receptor Cross-Talk | 1 | 2010 | 118 | 0.090 |
Why?
|
Isoantibodies | 3 | 1984 | 679 | 0.090 |
Why?
|
Protein Subunits | 2 | 2013 | 959 | 0.090 |
Why?
|
Salivary Glands, Minor | 1 | 2009 | 27 | 0.090 |
Why?
|
Histocompatibility Antigens | 1 | 1991 | 471 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 264 | 0.080 |
Why?
|
Promoter Regions, Genetic | 2 | 1997 | 5867 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2518 | 0.080 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2013 | 841 | 0.080 |
Why?
|
Endoplasmic Reticulum | 3 | 2003 | 1146 | 0.080 |
Why?
|
Research | 1 | 1997 | 1999 | 0.080 |
Why?
|
Automation | 1 | 2011 | 584 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2027 | 0.080 |
Why?
|
Cell Line, Transformed | 2 | 2003 | 897 | 0.080 |
Why?
|
Tissue Donors | 2 | 2001 | 2241 | 0.080 |
Why?
|
Twins, Monozygotic | 2 | 2003 | 458 | 0.080 |
Why?
|
Bone Marrow Cells | 2 | 2007 | 2509 | 0.080 |
Why?
|
Male | 20 | 2023 | 349776 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 1991 | 927 | 0.080 |
Why?
|
Women's Health | 1 | 1997 | 2033 | 0.080 |
Why?
|
Placebos | 1 | 2012 | 1674 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 4 | 1995 | 1369 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2021 | 7880 | 0.080 |
Why?
|
Mice, Inbred Strains | 4 | 1995 | 1826 | 0.070 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 906 | 0.070 |
Why?
|
Tuberculosis | 1 | 2020 | 1914 | 0.070 |
Why?
|
Kinetics | 1 | 2015 | 6476 | 0.070 |
Why?
|
Treatment Failure | 1 | 2013 | 2617 | 0.070 |
Why?
|
Interleukin-2 | 1 | 2013 | 1904 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5264 | 0.070 |
Why?
|
Fund Raising | 1 | 2006 | 47 | 0.070 |
Why?
|
Foundations | 1 | 2006 | 94 | 0.070 |
Why?
|
Cell Line | 5 | 2001 | 15993 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2018 | 14563 | 0.070 |
Why?
|
Mesonephros | 1 | 2005 | 41 | 0.070 |
Why?
|
Models, Biological | 2 | 2018 | 9582 | 0.070 |
Why?
|
Thyroiditis, Autoimmune | 2 | 1998 | 101 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13980 | 0.060 |
Why?
|
Dissent and Disputes | 1 | 2006 | 141 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2023 | 25609 | 0.060 |
Why?
|
Tongue | 1 | 2008 | 404 | 0.060 |
Why?
|
Mass Spectrometry | 2 | 2009 | 2203 | 0.060 |
Why?
|
Proteomics | 2 | 2009 | 3639 | 0.060 |
Why?
|
Middle Aged | 8 | 2020 | 213241 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1992 | 2540 | 0.060 |
Why?
|
Molecular Sequence Data | 4 | 2009 | 18107 | 0.060 |
Why?
|
Models, Immunological | 1 | 2006 | 527 | 0.060 |
Why?
|
Graves Disease | 2 | 1998 | 242 | 0.060 |
Why?
|
Base Sequence | 4 | 2002 | 12798 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2013 | 6620 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10629 | 0.060 |
Why?
|
Time Factors | 5 | 2014 | 40038 | 0.060 |
Why?
|
Ploidies | 1 | 2003 | 281 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2951 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19894 | 0.060 |
Why?
|
Administration, Intravesical | 1 | 2023 | 91 | 0.060 |
Why?
|
Transplantation, Homologous | 5 | 1995 | 4777 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 1989 | 1423 | 0.060 |
Why?
|
Cell Fusion | 1 | 2003 | 297 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2006 | 710 | 0.050 |
Why?
|
Mice, SCID | 1 | 2008 | 2718 | 0.050 |
Why?
|
Protein Biosynthesis | 2 | 2002 | 2123 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2003 | 318 | 0.050 |
Why?
|
Antigen-Presenting Cells | 2 | 1997 | 972 | 0.050 |
Why?
|
Erythrocytes | 2 | 1989 | 2455 | 0.050 |
Why?
|
Adolescent | 7 | 2015 | 85729 | 0.050 |
Why?
|
Antibody Formation | 1 | 2006 | 1402 | 0.050 |
Why?
|
Liver Transplantation | 1 | 1993 | 2119 | 0.050 |
Why?
|
Pancreatic Ducts | 1 | 2003 | 328 | 0.050 |
Why?
|
Immunologic Surveillance | 1 | 2002 | 93 | 0.050 |
Why?
|
Child | 6 | 2015 | 77637 | 0.050 |
Why?
|
Transplantation Chimera | 1 | 2004 | 613 | 0.050 |
Why?
|
I-kappa B Proteins | 1 | 2001 | 225 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 4386 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2004 | 2649 | 0.050 |
Why?
|
Hearing Loss | 1 | 2008 | 765 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5691 | 0.050 |
Why?
|
Finland | 2 | 2002 | 602 | 0.040 |
Why?
|
Bacterial Load | 1 | 2020 | 153 | 0.040 |
Why?
|
Serial Publications | 1 | 1999 | 10 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2020 | 352 | 0.040 |
Why?
|
Skin Transplantation | 1 | 1985 | 1074 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4839 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2942 | 0.040 |
Why?
|
NF-kappa B p50 Subunit | 1 | 1999 | 107 | 0.040 |
Why?
|
Cell Extracts | 1 | 1999 | 138 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2005 | 3701 | 0.040 |
Why?
|
Spain | 1 | 2020 | 464 | 0.040 |
Why?
|
DNA Primers | 2 | 2002 | 2891 | 0.040 |
Why?
|
Sex Factors | 2 | 2006 | 10394 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2015 | 57744 | 0.040 |
Why?
|
Young Adult | 3 | 2015 | 56392 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2001 | 844 | 0.040 |
Why?
|
Cytokines | 1 | 2013 | 7324 | 0.040 |
Why?
|
Antigens, Surface | 3 | 1990 | 1663 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2012 | 12020 | 0.040 |
Why?
|
Pancreas | 1 | 2005 | 1686 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2021 | 2085 | 0.040 |
Why?
|
Risk | 1 | 2009 | 9677 | 0.040 |
Why?
|
Aorta | 1 | 2005 | 2062 | 0.040 |
Why?
|
Protein Transport | 1 | 2003 | 1988 | 0.040 |
Why?
|
Genome, Human | 2 | 2003 | 4418 | 0.040 |
Why?
|
Peptide Mapping | 1 | 1997 | 263 | 0.040 |
Why?
|
Twins | 1 | 1998 | 339 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2001 | 804 | 0.040 |
Why?
|
Heart Atria | 1 | 1982 | 1357 | 0.030 |
Why?
|
Uterus | 1 | 2020 | 711 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 1997 | 462 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4568 | 0.030 |
Why?
|
Murine hepatitis virus | 1 | 1995 | 20 | 0.030 |
Why?
|
Phenotype | 3 | 2006 | 16361 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.030 |
Why?
|
Remission Induction | 1 | 2001 | 2384 | 0.030 |
Why?
|
Aged | 4 | 2023 | 163178 | 0.030 |
Why?
|
Protein Precursors | 1 | 1999 | 1154 | 0.030 |
Why?
|
Nephrectomy | 1 | 2001 | 1048 | 0.030 |
Why?
|
Proteome | 1 | 2005 | 1794 | 0.030 |
Why?
|
Mice, Nude | 1 | 2002 | 3680 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1677 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 1997 | 741 | 0.030 |
Why?
|
Twin Studies as Topic | 1 | 1995 | 104 | 0.030 |
Why?
|
Self Tolerance | 1 | 1995 | 125 | 0.030 |
Why?
|
Gene Frequency | 2 | 2002 | 3585 | 0.030 |
Why?
|
Reference Values | 2 | 1993 | 4974 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 29052 | 0.030 |
Why?
|
Transfection | 1 | 2003 | 5892 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25032 | 0.030 |
Why?
|
Biological Transport | 1 | 1999 | 2119 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2023 | 77410 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1994 | 402 | 0.030 |
Why?
|
alpha Catenin | 1 | 2013 | 38 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1783 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 63042 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 1995 | 492 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2002 | 3205 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1993 | 518 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 1995 | 608 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 1995 | 813 | 0.030 |
Why?
|
Transcription Factors | 2 | 2013 | 12209 | 0.030 |
Why?
|
Nuclear Family | 1 | 1993 | 318 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 1997 | 709 | 0.030 |
Why?
|
Ovariectomy | 1 | 1994 | 661 | 0.030 |
Why?
|
Mutation | 3 | 2003 | 29777 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 1862 | 0.030 |
Why?
|
Aging | 2 | 2005 | 8655 | 0.030 |
Why?
|
Acyltransferases | 1 | 2013 | 294 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9440 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2003 | 4803 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 5983 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 1994 | 9731 | 0.020 |
Why?
|
Guinea Pigs | 1 | 1993 | 1386 | 0.020 |
Why?
|
Species Specificity | 1 | 1995 | 2480 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7719 | 0.020 |
Why?
|
Xenopus | 1 | 1993 | 712 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4463 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1999 | 6311 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2013 | 697 | 0.020 |
Why?
|
Genetic Markers | 1 | 1997 | 2634 | 0.020 |
Why?
|
Cell Polarity | 1 | 2013 | 645 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7150 | 0.020 |
Why?
|
Morphogenesis | 1 | 2013 | 751 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 1991 | 517 | 0.020 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1991 | 482 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1992 | 541 | 0.020 |
Why?
|
Cadherins | 1 | 2013 | 907 | 0.020 |
Why?
|
Boronic Acids | 1 | 2013 | 965 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1994 | 1608 | 0.020 |
Why?
|
Alleles | 2 | 2002 | 6934 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 2009 | 246 | 0.020 |
Why?
|
Temperature | 1 | 1994 | 2202 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1989 | 1157 | 0.020 |
Why?
|
Kidney | 2 | 1994 | 7185 | 0.020 |
Why?
|
Lip | 1 | 2009 | 195 | 0.020 |
Why?
|
Muscles | 1 | 1993 | 1613 | 0.020 |
Why?
|
Secretory Rate | 1 | 2006 | 82 | 0.020 |
Why?
|
Salivation | 1 | 2006 | 22 | 0.020 |
Why?
|
Pyrazines | 1 | 2013 | 1230 | 0.020 |
Why?
|
Haplotypes | 1 | 1993 | 2779 | 0.020 |
Why?
|
Sheep | 1 | 1989 | 1437 | 0.020 |
Why?
|
Genotype | 2 | 2002 | 12944 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1999 | 5096 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1990 | 1588 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1995 | 3421 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9139 | 0.020 |
Why?
|
Salivary Glands | 1 | 2006 | 229 | 0.020 |
Why?
|
Outpatients | 1 | 2013 | 1488 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9944 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1999 | 3921 | 0.020 |
Why?
|
Genetic Testing | 1 | 1997 | 3439 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3504 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1989 | 985 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1993 | 2131 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6170 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2850 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 2004 | 269 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8436 | 0.010 |
Why?
|
Immune Sera | 1 | 1982 | 641 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2003 | 17439 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1993 | 2104 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 40545 | 0.010 |
Why?
|
Rats, Inbred Lew | 2 | 1992 | 1162 | 0.010 |
Why?
|
Family | 1 | 1991 | 3144 | 0.010 |
Why?
|
Pilot Projects | 1 | 1992 | 8316 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1982 | 796 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29140 | 0.010 |
Why?
|
Immunization | 1 | 1982 | 1255 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1984 | 1301 | 0.010 |
Why?
|
Rats | 4 | 1992 | 24250 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 6750 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1993 | 3712 | 0.010 |
Why?
|
Liver | 1 | 1993 | 7479 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13273 | 0.010 |
Why?
|
Dogs | 2 | 1992 | 3911 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2002 | 1996 | 0.010 |
Why?
|
Calcium | 1 | 1989 | 5755 | 0.010 |
Why?
|
Cattle | 2 | 1992 | 3917 | 0.010 |
Why?
|
Infant | 1 | 1997 | 35122 | 0.010 |
Why?
|
Child, Preschool | 1 | 1997 | 40964 | 0.010 |
Why?
|
Preoperative Care | 1 | 1982 | 2251 | 0.010 |
Why?
|
Analysis of Variance | 2 | 1992 | 6356 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 1997 | 1060 | 0.010 |
Why?
|
Hexuronic Acids | 1 | 1992 | 144 | 0.010 |
Why?
|
Glucuronic Acid | 1 | 1992 | 148 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39001 | 0.010 |
Why?
|
Swine | 2 | 1992 | 5909 | 0.010 |
Why?
|
United States | 1 | 1999 | 69859 | 0.010 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 1993 | 266 | 0.010 |
Why?
|
Alginates | 1 | 1992 | 252 | 0.010 |
Why?
|
Insulin Infusion Systems | 1 | 1992 | 212 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1992 | 371 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11360 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13691 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1991 | 1799 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4320 | 0.000 |
Why?
|
Risk Factors | 1 | 1993 | 72252 | 0.000 |
Why?
|
Concanavalin A | 1 | 1984 | 191 | 0.000 |
Why?
|
Rats, Inbred Strains | 1 | 1984 | 2184 | 0.000 |
Why?
|
Databases, Factual | 1 | 1997 | 7729 | 0.000 |
Why?
|
Glucose | 1 | 1991 | 4398 | 0.000 |
Why?
|
Immunity, Innate | 1 | 1984 | 2961 | 0.000 |
Why?
|